STAT+: EU and US advisers split over AstraZeneca breast cancer drug
STAT [Unofficial]
May 22, 2026
Merck-Kelun ADC outperforms Keytruda in trial, a closely watched Parkinson’s drug fails, and more biotech news from The Readout
Discussion in the ATmosphere